A former subject in the (b)(6) clinical trial (ide (b)(4); subject id (b)(6)) was originally converted to a maestro rechargeable system on (b)(6) 2015.The system, including model 2002 rechargeable neuroregulator, model 2200a-47e anterior lead, and model 2200p-47e posterior lead were replaced on (b)(6) 2016 (refer to mdr 3005025697-2017-00005 through mdr 3005025697-2017-00007 for details on original rechargeable system removal due to excessive manipulation).On (b)(6) 2016, the site reported that alerts for low impedance were experienced at follow-up, noting that the ring electrodes were places quite close together at implant.On (b)(6) 2016, it was reported that low impedance measurements were again experienced.Radiograph review suggested that the ring electrodes were in very close proximity to each other with twisting of the leads near the neuroregulator.The replacement system was explanted on (b)(6) , 2016.Mdr's related to this issues are: mdr 3005025697-2017-00008: model 2002 rechargeable neuroregulator, mdr 3005025697-2017-00009: model 2200a-47e anterior lead, mdr 3005025697-2017-00010: model 2200p-47e posterior lead.
|